Little Green Pharma Ltd banner

Little Green Pharma Ltd
ASX:LGP

Watchlist Manager
Little Green Pharma Ltd Logo
Little Green Pharma Ltd
ASX:LGP
Watchlist
Price: 0.11 AUD -4.35% Market Closed
Market Cap: AU$33.6m

Cash Flow Statement

Cash Flow Statement
Little Green Pharma Ltd

Rotate your device to view
Cash Flow Statement
Currency: AUD
Jun-2020 Dec-2020 Jun-2021 Dec-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025 Sep-2025
Operating Cash Flow
Net Income
(9)
(3)
25
16
(18)
(26)
(9)
(4)
(8)
(9)
(5)
(2)
Depreciation & Amortization
0
0
1
1
1
2
3
4
3
3
4
4
Stock-Based Compensation
1
3
3
3
2
3
2
2
2
0
2
3
Other Non-Cash Items
1
2
(24)
(24)
1
2
1
1
3
3
4
4
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
1
(1)
(7)
(8)
(1)
(2)
(2)
(3)
2
6
(4)
(7)
Cash from Operating Activities
(6)
N/A
(2)
+66%
(5)
-151%
(14)
-178%
(17)
-20%
(24)
-42%
(7)
+72%
(2)
+78%
0
N/A
3
+3 829%
(1)
N/A
(1)
-55%
Investing Cash Flow
Capital Expenditures
(7)
(5)
(12)
(17)
(8)
(10)
(5)
(3)
(1)
(1)
(1)
(1)
Other Items
(0)
(0)
(1)
0
0
0
(9)
(10)
(1)
(0)
(0)
(0)
Cash from Investing Activities
(7)
N/A
(5)
+28%
(13)
-149%
(18)
-43%
(8)
+58%
(10)
-28%
(14)
-43%
(14)
+3%
(3)
+79%
(2)
+43%
(1)
+29%
(1)
+10%
Financing Cash Flow
Net Issuance of Common Stock
10
11
56
55
1
0
10
10
0
(0)
0
0
Net Issuance of Debt
9
0
(0)
(0)
4
(3)
4
8
(5)
(2)
(1)
(0)
Other
(2)
(2)
(2)
0
0
0
(1)
0
0
0
0
0
Cash from Financing Activities
17
N/A
9
-44%
54
+472%
53
-2%
5
-91%
(2)
N/A
13
N/A
17
+32%
(5)
N/A
(2)
+49%
(1)
+78%
(0)
+82%
Change in Cash
Effect of Foreign Exchange Rates
(0)
(0)
0
0
(0)
(0)
0
0
0
0
(0)
0
Net Change in Cash
4
N/A
2
-42%
36
+1 536%
20
-43%
(20)
N/A
(36)
-80%
(8)
+79%
2
N/A
(7)
N/A
(1)
+82%
(3)
-91%
(3)
+3%
Free Cash Flow
Free Cash Flow
(13)
N/A
(7)
+45%
(17)
-138%
(31)
-87%
(25)
+21%
(34)
-38%
(12)
+65%
(5)
+60%
(1)
+71%
1
N/A
(2)
N/A
(2)
-31%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett